BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10442185)

  • 21. [Long-term results of comprehensive treatment for cervical cancer with poor prognosis].
    Vishnevskaia EE; Kosenko IA
    Vopr Onkol; 1999; 45(4):420-3. PubMed ID: 10532103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neoadjuvant chemotherapy with cisplatin and CPT-11 for advanced cervical cancer].
    Nishio S; Kumagai S; Hirai N; Tomioka Y; Oota S; Fujiyoshi K; Hasuo Y; Sugiyama T; Nishida T; Kamura T
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):429-35. PubMed ID: 10740637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoradiation: the new gold standard for non-surgical treatment of cervical cancer.
    Symonds P
    Clin Oncol (R Coll Radiol); 2002 Jun; 14(3):201-2. PubMed ID: 12109822
    [No Abstract]   [Full Text] [Related]  

  • 24. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.
    Loizzi V; Cormio G; Vicino M; Selvaggi L
    Gynecol Obstet Invest; 2008; 65(2):96-103. PubMed ID: 17878736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flashback Foreword: Concurrent Chemotherapy/Radiotherapy for Cervical Cancer.
    Fleming GF
    J Clin Oncol; 2023 Oct; 41(29):4603-4604. PubMed ID: 37797408
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of high-risk cervical cancer.
    Pearcey RG; Mohamed IG; Hanson J
    N Engl J Med; 1999 Aug; 341(9):695-6; author reply 696-7. PubMed ID: 10475822
    [No Abstract]   [Full Text] [Related]  

  • 28. Concurrent weekly cis-platinum and radiotherapy in advanced cervical cancer: a preliminary dose escalating toxicity study.
    Twiggs LB; Potish RA; McIntyre S; Adcock LL; Savage JE; Prem KA
    Gynecol Oncol; 1986 Jun; 24(2):143-8. PubMed ID: 3086189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
    N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M; Martínez-Monge R; García-Foncillas J; Azinovic I; Aristu J; López-García G; Brugarolas A
    Gynecol Oncol; 1999 Jul; 74(1):30-7. PubMed ID: 10385548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-arterial chemotherapy with cisplatin followed by radical radiotherapy for locally advanced cervical cancer.
    Sueyama H; Nakano M; Sakumoto K; Toita T; Takizawa Y; Moromizato H; Kakihana Y; Kushi A; Moromizato H; Higashi M
    Gynecol Oncol; 1995 Dec; 59(3):327-32. PubMed ID: 8522249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
    Dunst J; Haensgen G
    Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical treatment of locally advanced and recurrent cervical carcinoma: overview on current standard and new developments.
    Höckel M
    Onkologie; 2003 Oct; 26(5):452-5. PubMed ID: 14605461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival benefits of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy in locally advanced chemoresistant cervical cancer.
    Choi YS; Sin JI; Kim JH; Ye GW; Shin IH; Lee TS
    J Korean Med Sci; 2006 Aug; 21(4):683-9. PubMed ID: 16891813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care.
    Thomas GM
    Semin Radiat Oncol; 2000 Jan; 10(1):44-50. PubMed ID: 10671658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
    Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
    Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern management of locally advanced cervical carcinoma.
    Dueñas-Gonzalez A; Cetina L; Mariscal I; de la Garza J
    Cancer Treat Rev; 2003 Oct; 29(5):389-99. PubMed ID: 12972357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in chemoradiotherapy for locally advanced cancer of the cervix.
    Kim RY; Alvarez RD
    Oncology (Williston Park); 2000 Sep; 14(9):1327-31, 1335; discussion 1336-8. PubMed ID: 11033830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current role of neoadjuvant chemotherapy in the management of cervical carcinoma.
    González-Martín A; González-Cortijo L; Carballo N; Garcia JF; Lapuente F; Rojo A; Chiva LM
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S36-40. PubMed ID: 18586309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer?
    Lehman M; Thomas G
    Int J Gynecol Cancer; 2001; 11(2):87-99. PubMed ID: 11328406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.